PAM
SPPI

Paradigm Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Paradigm Asset Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15,800
Closed -$70K – 670
2016
Q4 		$70K Sell
15,800
-500
-3% -$2.1K 0.01% 464
2016
Q3 		$76.1K Buy
16,300
+1,000
+7% +$5.92K 0.01% 473
2016
Q2 		$101K Buy
+15,300
New +$108K 0.02% 449

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Paradigm Asset Management's SPPI Position: Q1 2017 in Review

Paradigm Asset Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2017, closing a stake of 15,800 shares — an estimated $70K sold.

Paradigm Asset Management first reported a position in SPPI in Q2 2016 and held it in 3 quarters. The position peaked at $101K in Q2 2016. 128 funds tracked by Wall St. Rank hold SPPI as of Q1 2017.

  • Paradigm Asset Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Paradigm Asset Management sold 15,800 Spectrum Pharmaceuticals Inc shares in Q1 2017, an estimated $70K.
  • Paradigm Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2016 and held it in 3 quarters.
  • Paradigm Asset Management's Spectrum Pharmaceuticals Inc position peaked at $101K in Q2 2016.
  • 128 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2017.

Based on Paradigm Asset Management's 13F filing for Q1 2017, filed 12 May 2017.